Replies to post #422548 on NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

This includes the tumor tissues used to prepare the lysate for DCVax-L products, and the immune cells that comprise the active ingredient of DCVax-L (emphasis added).

The Sawston facility must also be certified and licensed by MHRA in order to be able to manufacture products such as DCVax-L (emphasis added).

Thus while they specifically reference DCVax-L they are by no means closing the door on the licensed facility being used for other things. They are not saying it will be but nothing here says that it won't be either and that is my point.

We've been down this road before but hopefully this time will be different and the job postings mean what we hope they mean.